{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:12:07Z","timestamp":1788793927301,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00415-026-14110-7","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:56:24Z","timestamp":1788749784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A comparison study of thymectomy outcomes in young and older patients with non-thymomatous myasthenia gravis"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6626-6601","authenticated-orcid":false,"given":"Morgan E.","family":"Heber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-2168","authenticated-orcid":false,"given":"Yadi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-3406","authenticated-orcid":false,"given":"Daniel P.","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-8927","authenticated-orcid":false,"given":"Yuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"14110_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fimmu.2020.00212","volume":"11","author":"K Lazaridis","year":"2020","unstructured":"Lazaridis K, Tzartos SJ (2020) Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol 11:212. https:\/\/doi.org\/10.3389\/fimmu.2020.00212","journal-title":"Front Immunol"},{"key":"14110_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649171","volume":"16","author":"N Matsui","year":"2025","unstructured":"Matsui N, Ohigashi I, Marx A (2025) Thymus research in relation to myasthenia gravis: a new perspective on cell subpopulations and future directions. Front Immunol 16:1649171. https:\/\/doi.org\/10.3389\/fimmu.2025.1649171","journal-title":"Front Immunol"},{"issue":"2","key":"14110_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A (2022) Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol 21(2):176\u2013188. https:\/\/doi.org\/10.1016\/S1474-4422(21)00297-0","journal-title":"Lancet Neurol"},{"issue":"2","key":"14110_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.thorsurg.2018.12.011","volume":"29","author":"JD Cooper","year":"2019","unstructured":"Cooper JD (2019) History of thymectomy for myasthenia gravis. Thorac Surg Clin 29(2):151\u2013158. https:\/\/doi.org\/10.1016\/j.thorsurg.2018.12.011","journal-title":"Thorac Surg Clin"},{"issue":"3","key":"14110_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11940-002-0037-x","volume":"4","author":"GS Gronseth","year":"2002","unstructured":"Gronseth GS, Barohn RJ (2002) Thymectomy for Myasthenia Gravis. Curr Treat Options Neurol 4(3):203\u2013209. https:\/\/doi.org\/10.1007\/s11940-002-0037-x","journal-title":"Curr Treat Options Neurol"},{"issue":"6","key":"14110_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2017","unstructured":"Wolfe GI, Kaminski HJ, Aban IB et al (2017) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375(6):511\u2013522. https:\/\/doi.org\/10.1056\/NEJMoa1602489","journal-title":"N Engl J Med"},{"issue":"1","key":"14110_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/wnl.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology 55(1):16\u201323. https:\/\/doi.org\/10.1212\/wnl.55.1.16. (PMID: 10891897)","journal-title":"Neurology"},{"issue":"1","key":"14110_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/mus.28417","volume":"72","author":"K Ruzhansky","year":"2025","unstructured":"Ruzhansky K, Li Y, Wolfe GI, Muppidi S, Guptill JT, Hehir MK, Dimachkie MM, Kaminski HJ, Howard JF Jr, Narayanaswami P (2025) Standardization of myasthenia gravis outcome measures in clinical practice: a report of the MGFA task force. Muscle Nerve 72(1):56\u201365. https:\/\/doi.org\/10.1002\/mus.28417","journal-title":"Muscle Nerve"},{"issue":"1","key":"14110_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1034\/j.1600-0404.2000.00014.x","volume":"101","author":"LC Werneck","year":"2000","unstructured":"Werneck LC, Cunha FM, Scola RH (2000) Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment. Acta Neurol Scand 101(1):41\u201346 (PMID: 10660151)","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"14110_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1468-1331.2002.00352.x","volume":"9","author":"F Romi","year":"2002","unstructured":"Romi F, Gilhus NE, Varhaug JE, Myking A, Skeie GO, Aarli JA (2002) Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis. Eur J Neurol 9(1):55\u201361. https:\/\/doi.org\/10.1046\/j.1468-1331.2002.00352.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"14110_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.athoracsur.2003.11.040","volume":"78","author":"M Zieli\u0144ski","year":"2004","unstructured":"Zieli\u0144ski M, Kuzdzal J, Szlubowski A, Soja J (2004) Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis. Ann Thorac Surg 78(1):253\u2013258. https:\/\/doi.org\/10.1016\/j.athoracsur.2003.11.040. (PMID: 15223438)","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"14110_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.clineuro.2007.08.006","volume":"109","author":"N Kawaguchi","year":"2007","unstructured":"Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Arimura K, Osame M, Hattori T (2007) Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin Neurol Neurosurg 109(10):858\u2013861. https:\/\/doi.org\/10.1016\/j.clineuro.2007.08.006","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"14110_CR13","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/icvts\/ivv176","volume":"21","author":"Z Liu","year":"2015","unstructured":"Liu Z, Yang J, Lin L, Huang J, Jiang G (2015) Unilateral video-assisted thoracoscopic extended thymectomy offers long-term outcomes equivalent to that of the bilateral approach in the treatment of non-thymomatous myasthenia gravis. Interact Cardiovasc Thorac Surg 21(5):610\u2013615. https:\/\/doi.org\/10.1093\/icvts\/ivv176","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"14110_CR14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00415-015-7673-z","volume":"262","author":"A Uzawa","year":"2015","unstructured":"Uzawa A, Kawaguchi N, Kanai T, Himuro K, Oda F, Yoshida S, Yoshino I, Kuwabara S (2015) Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. J Neurol 262(4):1019\u20131023. https:\/\/doi.org\/10.1007\/s00415-015-7673-z","journal-title":"J Neurol"},{"issue":"4","key":"14110_CR15","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00415-019-09222-2","volume":"266","author":"SW Kim","year":"2019","unstructured":"Kim SW, Choi YC, Kim SM, Shim HS, Shin HY (2019) Effect of thymectomy in elderly patients with non-thymomatous generalized myasthenia gravis. J Neurol 266(4):960\u2013968. https:\/\/doi.org\/10.1007\/s00415-019-09222-2","journal-title":"J Neurol"},{"issue":"1","key":"14110_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01860-y","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Chen Y, Zhang H, Yang Z, Zhang P (2021) Effects of thymectomy on late-onset non-thymomatous myasthenia gravis: systematic review and meta-analysis. Orphanet J Rare Dis 16(1):232. https:\/\/doi.org\/10.1186\/s13023-021-01860-y","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"14110_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/WCO.0000000000001189","volume":"36","author":"J Rath","year":"2023","unstructured":"Rath J, Moser B, Zimprich F (2023) Thymectomy in myasthenia gravis. Curr Opin Neurol 36(5):416\u2013423. https:\/\/doi.org\/10.1097\/WCO.0000000000001189","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"14110_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13424-2","volume":"272","author":"E Latini","year":"2025","unstructured":"Latini E, Guida M, Zirafa CC, Rizzo S, Cepele A, Romano G, Aprile V, Lucchi M, Siciliano G, Ricciardi R, Maestri Tassoni M (2025) Long-term effectiveness of thymectomy in late-onset myasthenia gravis. J Neurol 272(11):714. https:\/\/doi.org\/10.1007\/s00415-025-13424-2","journal-title":"J Neurol"},{"issue":"3","key":"14110_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ana.78093","volume":"99","author":"J Chen","year":"2026","unstructured":"Chen J, Su C, Feng L et al (2026) Effects of thymectomy in late-onset myasthenia gravis: a multi-center longitudinal retrospective study. Ann Neurol 99(3):629\u2013638. https:\/\/doi.org\/10.1002\/ana.78093","journal-title":"Ann Neurol"},{"issue":"11","key":"14110_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70388","volume":"32","author":"L Huang","year":"2025","unstructured":"Huang L, Li F, Li Z et al (2025) Robotic extended thymectomy in late-onset myasthenia gravis: a 21-year retrospective cohort study of 172 patients. Eur J Neurol 32(11):e70388. https:\/\/doi.org\/10.1111\/ene.70388","journal-title":"Eur J Neurol"},{"issue":"3","key":"14110_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2020","unstructured":"Narayanaswami P, Sanders DB, Wolfe G et al (2020) International consensus guidance for management of myasthenia gravis: 2020 update. Neurology 96(3):114\u2013122. https:\/\/doi.org\/10.1212\/WNL.0000000000011124","journal-title":"Neurology"},{"issue":"9","key":"14110_CR22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41379-022-01070-2","volume":"35","author":"J Sarkkinen","year":"2022","unstructured":"Sarkkinen J, Dunkel J, Tuulasvaara A, Huuskonen A, Atula S, Kek\u00e4l\u00e4inen E, Laakso SM (2022) Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia gravis after thymectomy. Mod Pathol 35(9):1168\u20131174. https:\/\/doi.org\/10.1038\/s41379-022-01070-2","journal-title":"Mod Pathol"},{"issue":"1","key":"14110_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.athoracsur.2010.08.041","volume":"91","author":"Z Chen","year":"2011","unstructured":"Chen Z, Luo H, Peng Y, Cai L, Zhang J, Su C, Zou J (2011) Comparative clinical features and immune responses after extended thymectomy for myasthenia gravis in patients with atrophic versus hyperplastic thymus. Ann Thorac Surg 91(1):212\u2013218. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.08.041","journal-title":"Ann Thorac Surg"},{"key":"14110_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneuroim.2017.01.005","volume":"305","author":"K Nakahara","year":"2017","unstructured":"Nakahara K, Nakane S, Nakajima M, Yamashita S, Mori T, Ando Y (2017) Effect of thymectomy for thymic atrophy in myasthenia gravis: a retrospective study on 93 patients. J Neuroimmunol 305:182\u2013185. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.01.005","journal-title":"J Neuroimmunol"},{"issue":"4","key":"14110_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1212\/wnl.56.4.572","volume":"56","author":"HD Katzberg","year":"2001","unstructured":"Katzberg HD, Aziz T, Oger J (2001) In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies. Neurology 56(4):572\u2013573. https:\/\/doi.org\/10.1212\/wnl.56.4.572","journal-title":"Neurology"},{"key":"14110_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2013.12.006","volume":"52","author":"WY Chuang","year":"2014","unstructured":"Chuang WY, Str\u00f6bel P, Bohlender-Willke AL, Rieckmann P, Nix W, Schalke B, Gold R, Opitz A, Klinker E, Inoue M, M\u00fcller-Hermelink HK, Saruhan-Direskeneli G, Bugert P, Willcox N, Marx A (2014) Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of na\u00efve T cells. J Autoimmun 52:122\u2013129. https:\/\/doi.org\/10.1016\/j.jaut.2013.12.006","journal-title":"J Autoimmun"},{"key":"14110_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00660","volume":"11","author":"C Rodolico","year":"2020","unstructured":"Rodolico C, Bonanno C, Toscano A, Vita G (2020) MuSK-associated myasthenia gravis: clinical features and management. Front Neurol 11:660. https:\/\/doi.org\/10.3389\/fneur.2020.00660","journal-title":"Front Neurol"},{"issue":"3","key":"14110_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ana.20386","volume":"57","author":"MI Leite","year":"2005","unstructured":"Leite MI, Str\u00f6bel P, Jones M et al (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57(3):444\u2013448. https:\/\/doi.org\/10.1002\/ana.20386","journal-title":"Ann Neurol"},{"issue":"5","key":"14110_CR29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.5692\/clinicalneurol.53.372","volume":"53","author":"A Ito","year":"2013","unstructured":"Ito A, Sasaki R, Ii Y, Nakayama S, Motomura M, Tomimoto H (2013) Rinsho Shinkeigaku 53(5):372\u2013375. https:\/\/doi.org\/10.5692\/clinicalneurol.53.372","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"14110_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14712590802588831","volume":"9","author":"JM Ponseti","year":"2009","unstructured":"Ponseti JM, Caritg N, Gamez J, L\u00f3pez-Cano M, Vilallonga R, Armengol M (2009) A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis. Expert Opin Biol Ther 9(1):1\u20138. https:\/\/doi.org\/10.1517\/14712590802588831","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"14110_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1056\/NEJMoa2302892","volume":"389","author":"KA Kooshesh","year":"2023","unstructured":"Kooshesh KA, Foy BH, Sykes DB, Gustafsson K, Scadden DT (2023) Health consequences of thymus removal in adults. N Engl J Med 389(5):406\u2013417. https:\/\/doi.org\/10.1056\/NEJMoa2302892","journal-title":"N Engl J Med"},{"issue":"18","key":"14110_CR32","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJMc2310640","volume":"389","author":"Morena J; Duke Myasthenia Gravis Physicians","year":"2023","unstructured":"Morena J; Duke Myasthenia Gravis Physicians (2023) Health Consequences of Thymus Removal in Adults. N Engl J Med 389(18):1724\u20131725. https:\/\/doi.org\/10.1056\/NEJMc2310640","journal-title":"N Engl J Med"},{"issue":"18","key":"14110_CR33","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJMc2310640","volume":"389","author":"I Ilonen","year":"2023","unstructured":"Ilonen I, Kyt\u00f6 V, Kek\u00e4l\u00e4inen E (2023) Health Consequences of Thymus Removal in Adults. N Engl J Med 389(18):1725\u20131726. https:\/\/doi.org\/10.1056\/NEJMc2310640","journal-title":"N Engl J Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14110-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14110-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14110-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:03:38Z","timestamp":1788793418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-14110-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["14110"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14110-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"14 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Financial disclosures and conflicts of interest: Dr. Daniel P. Raymond holds equity interest for Bristol Myers Squibb and Zimmer Biomet and has consulted for KLS Martin. Dr. Yuebing Li has consulted for Alexion, Amgen, Argenx, Johnson & Johnson, Vertex, and has received grant support from Argenx. Dr. Morgan\u00a0E. Heber and Ms. Yadi Li do not have any disclosures. The authors declare that they do not have any conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Cleveland Clinic Institutional Review Board (IRB). The IRB waived the need for individual patient consent for this study. The study complied with the Helsinki declaration.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"566"}}